Discover Australian Clinical Labs' FY22 results, with a PE ratio of 4, potentially the cheapest ASX company ever! Is it a value trap or a penny stock poised for MASSIVE buyout? ACL's lowball offer for Healius HLS raises eyebrows. Profit upgrades announced, the 3rd in three months. Don't miss out on this potential investment opportunity!